Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
DNOW Inc
DNOW
$2.83B
| $57.8M | 0.08% |
3,788,914
+93,200
| +3% | +$1.41M |
2016 Q1
38 quarters
|
|
302
Pinterest
PINS
$11.6B
| $57.7M | 0.08% |
1,794,871
-643,915
| -26% | -$23.4M |
2024 Q4
3 quarters
|
|
303
PTC Therapeutics
PTCT
$5.22B
| $56.9M | 0.08% |
927,300
-36,000
| -4% | -$1.88M |
2023 Q3
8 quarters
|
|
304
Johnson & Johnson
JNJ
$618B
| $56.9M | 0.08% |
306,747
-576,443
| -65% | -$98.8M |
2024 Q4
3 quarters
|
|
305
DexCom
DXCM
$31.9B
| $56.6M | 0.07% |
841,564
+143,762
| +21% | +$11.4M |
2023 Q4
7 quarters
|
|
306
EPR Properties
EPR
$4.17B
| $56.6M | 0.07% |
975,823
-601,794
| -38% | -$33.8M |
2021 Q2
17 quarters
|
|
307
Takeda Pharmaceutical
TAK
$59.2B
| $56.6M | 0.07% |
3,864,600
+565,400
| +17% | +$8.4M |
2019 Q2
25 quarters
|
|
308
NIO
NIO
$8.54B
| $56.5M | 0.07% |
7,413,440
-876,000
| -11% | -$4.72M |
2024 Q2
5 quarters
|
|
309
Herbalife
HLF
$1.34B
| $56.5M | 0.07% |
6,688,468
-215,600
| -3% | -$2.03M |
2015 Q3
40 quarters
|
|
310
WD-40
WDFC
$2.74B
| $56.4M | 0.07% |
285,561
+7,300
| +3% | +$1.58M |
2013 Q2
49 quarters
|
|
311
Veeva Systems
VEEV
$46.1B
| $56M | 0.07% |
188,000
-324,600
| -63% | -$91.4M |
2024 Q3
4 quarters
|
|
312
Collegium Pharmaceutical
COLL
$720M
| $56M | 0.07% |
1,599,189
+78,019
| +5% | +$2.71M |
2019 Q2
25 quarters
|
|
313
FirstEnergy
FE
$26B
| $55.9M | 0.07% |
1,220,808
+302,608
| +33% | +$12.9M |
2024 Q3
4 quarters
|
|
314
Watsco Inc
WSO
$11.6B
| $55.9M | 0.07% |
138,200
+89,500
| +184% | +$38.3M |
2024 Q3
4 quarters
|
|
315
D-Wave Quantum Inc
QBTS
$5.54B
| $55.7M | 0.07% |
2,253,542
-1,537,800
| -41% | -$28M |
2025 Q2
1 quarter
|
|
316
Intercontinental Exchange
ICE
$87.2B
| $55.4M | 0.07% |
328,839
+68,717
| +26% | +$12.3M |
2024 Q1
6 quarters
|
|
317
Madrigal Pharmaceuticals
MDGL
$11B
| $55.4M | 0.07% |
120,682
+109,846
| +1,014% | +$41M |
2024 Q3
4 quarters
|
|
318
Trade Desk
TTD
$5.83B
| $55.3M | 0.07% |
1,127,600
+1,022,046
| +968% | +$64.9M |
2024 Q1
6 quarters
|
|
319
iShares 0-5 Year TIPS Bond ETF
STIP
$16.4B
| $55.2M | 0.07% |
534,400
-77,700
| -13% | -$8.01M |
2023 Q4
7 quarters
|
|
320
Rhythm Pharmaceuticals
RYTM
$6.17B
| $55.2M | 0.07% |
546,593
+231,700
| +74% | +$21.5M |
2025 Q1
2 quarters
|
|
321
LegalZoom.com
LZ
$1.01B
| $55.1M | 0.07% |
5,309,955
+307,805
| +6% | +$3.07M |
2022 Q3
12 quarters
|
|
322
Pacira BioSciences
PCRX
$1.45B
| $55.1M | 0.07% |
2,138,201
-257,400
| -11% | -$6.32M |
2018 Q3
28 quarters
|
|
323
IDT Corp
IDT
$2B
| $55.1M | 0.07% |
1,052,506
-47,333
| -4% | -$2.95M |
2013 Q2
49 quarters
|
|
|
VISN
324
Vistance Networks Inc
VISN
$1.39B
| $55M | 0.07% |
3,550,900
-220,100
| -6% | -$2.86M |
2022 Q4
11 quarters
|
|
|
HSII
325
DELISTED
Heidrick & Struggles
HSII
| $54.6M | 0.07% |
1,096,340
-5,400
| -0.5% | -$260K |
2013 Q2
49 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.